Evidence map›Paper›PMID 22210111›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Affinity of talin-1 for the β3-integrin cytosolic domain is modulated by its phospholipid bilayer environment.

David T Moore, Patrik Nygren, Hyunil Jo, Kathleen Boesze-Battaglia, Joel S Bennett, William F DeGrado

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. PI(4,5)P2: signaling the plasma membrane.The Biochemical journal · 2022
    Article
  8. Review
  9. Article
  10. Review of PIP2 in Cellular Signaling, Functions and Diseases.International journal of molecular sciences · 2020
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

David T MooreDepartment of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Patrik Nygren
Hyunil Jo
Kathleen Boesze-Battaglia
Joel S Bennett
William F DeGrado
University of Pennsylvania · US

Funding

Subcellular Mechanisms pf Platelet ActivationP01HL040387 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI BENNETT, JOEL S. · 1988 to 2018
$35.5M
THE ROLE OF SEMA4D/CD100 AND ITS RECEPTORS IN PLATELET BIOLOGY AND THROMBOSISP50HL081012 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI BRASS, LAWRENCE · 2006 to 2010
$11.9M
MEMBRANE FUSION IN RETINAL ROD OUTER SEGMENTSR01EY010420 · NEI · UNIV OF MED/DENT NJ-SCH OSTEOPATHIC MED · PI BOESZE-BATTAGLIA, KATHLEEN · 1999 to 2016
$4.7M
Nikon A1R confocal laser microscope system for live cell imagingS10RR026365 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI BOESZE-BATTAGLIA, KATHLEEN · 2010 to 2010
$500k
A Role for Melanoregulin in RPE-mediated PhagocytosisR21EY018705 · NEI · UNIVERSITY OF PENNSYLVANIA · PI BOESZE-BATTAGLIA, KATHLEEN · 2009 to 2010
$437k
MEMBRANE FUSION IN RETINAL ROD OUTER SEGMENTSR29EY010420 · NEI · UNIV OF MED/DENT NJ-SCH OSTEOPATHIC MED · PI BOESZE-BATTAGLIA, KATHLEEN B · 1994 to 1998
–
NCRR NIH HHS S10 RR026365NEI NIH HHS EY18705NEI NIH HHS R01 EY010420NEI NIH HHS R21 EY018705NEI NIH HHS R29 EY010420NHLBI NIH HHS HL40387NHLBI NIH HHS HL81012NHLBI NIH HHS P01 HL040387NHLBI NIH HHS P50 HL081012
6 · The paper itself

Abstract

Binding of the talin-1 FERM (4.1/ezrin/radixin/moesin) domain to the β3 cytosolic tail causes activation of the integrin αIIbβ3. The FERM domain also binds to acidic phospholipids. Although much is known about the interaction of talin-1 with integrins and lipids, the relative contribution of each interaction to integrin regulation and possible synergy between them remain to be clarified. Here, we examined the thermodynamic interplay between FERM domain binding to phospholipid bilayers and to its binding sites in the β3 tail. We found that although both the F0F1 and F2F3 subdomains of the talin-1 FERM domain bind acidic bilayers, the full-length FERM domain binds with an affinity similar to F2F3, indicating that F0F1 contributes little to the overall interaction. When free in solution, the β3 tail has weak affinity for the FERM domain. However, appending the tail to acidic phospholipids increased its affinity for the FERM domain by three orders of magnitude. Nonetheless, the affinity of the FERM for the appended tail was similar to its affinity for binding to bilayers alone. Thus, talin-1 binding to the β3 tail is a ternary interaction dominated by a favorable surface interaction with phospholipid bilayers and set by lipid composition. Nonetheless, interactions between the FERM domain, the β3 tail, and lipid bilayers are not optimized for a high-affinity synergistic interaction, even at the membrane surface. Instead, the interactions appear to be tuned in such a way that the equilibrium between inactive and active integrin conformations can be readily regulated.

Indexed as

Cytoskeletal ProteinsCytosolDextransEzrinImmobilized ProteinsIntegrin beta3KineticsLipid BilayersMembrane ProteinsMicrofilament ProteinsModels, MolecularPhosphatidylinositol 4,5-DiphosphatePhospholipidsProtein BindingProtein Structure, TertiarySurface Plasmon Resonancecarboxymethyl dextranCytoskeletal ProteinsDextransEzrinImmobilized ProteinsIntegrin beta3Lipid BilayersMembrane ProteinsMicrofilament ProteinsmoesinPhosphatidylinositol 4,5-DiphosphatePhospholipidsradixinTalin

Identifiers

PMID22210111
PMCPMC3271903
OpenAlexW2114319047

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.